TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Panacea Biotec Limited ( (IN:PANACEABIO) ) has shared an announcement.
Panacea Biotec Limited has published its unaudited standalone and consolidated financial results for the quarter ending June 30, 2025, in compliance with SEBI regulations. The financial results were published in Business Standard and Desh Sewak newspapers, indicating the company’s commitment to transparency and regulatory compliance. This announcement may impact the company’s stakeholders by providing insights into its financial health and operational performance.
More about Panacea Biotec Limited
Panacea Biotec Limited operates in the biotechnology and pharmaceutical industry, focusing on the development and manufacturing of vaccines and pharmaceutical formulations. The company is known for its contributions to healthcare through innovative solutions and has a market focus on both domestic and international markets.
Average Trading Volume: 18,236
Technical Sentiment Signal: Buy
Current Market Cap: 25.78B INR
For a thorough assessment of PANACEABIO stock, go to TipRanks’ Stock Analysis page.